Vanguard Group’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.66M | Buy |
3,329,721
+986,160
| +42% | +$2.34M | ﹤0.01% | 3152 |
|
|
2025
Q3 | $7.15M | Buy |
2,343,561
+292,923
| +14% | +$914K | ﹤0.01% | 3153 |
|
|
2025
Q2 | $5.17M | Buy |
2,050,638
+1,309,473
| +177% | +$3.13M | ﹤0.01% | 3206 |
|
|
2025
Q1 | $1.12M | Buy |
741,165
+281,616
| +61% | +$498K | ﹤0.01% | 3677 |
|
|
2024
Q4 | $515K | Hold |
459,549
| – | – | ﹤0.01% | 3947 |
|
|
2024
Q3 | $411K | Hold |
459,549
| – | – | ﹤0.01% | 4017 |
|
|
2024
Q2 | $469K | Hold |
459,549
| – | – | ﹤0.01% | 4028 |
|
|
2024
Q1 | $565K | Hold |
459,549
| – | – | ﹤0.01% | 3985 |
|
|
2023
Q4 | $754K | Buy |
459,549
+198,213
| +76% | +$264K | ﹤0.01% | 3913 |
|
|
2023
Q3 | $363K | Hold |
261,336
| – | – | ﹤0.01% | 4145 |
|
|
2023
Q2 | $711K | Buy |
261,336
+513
| +0.2% | +$1.03K | ﹤0.01% | 4009 |
|
|
2023
Q1 | $543K | Sell |
260,823
-9,096
| -3% | -$26.9K | ﹤0.01% | 4106 |
|
|
2022
Q4 | $812K | Buy |
269,919
+131
| +0% | +$544 | ﹤0.01% | 3980 |
|
|
2022
Q3 | $1.29M | Hold |
269,788
| – | – | ﹤0.01% | 3919 |
|
|
2022
Q2 | $1.38M | Hold |
269,788
| – | – | ﹤0.01% | 3972 |
|
|
2022
Q1 | $1.69M | Hold |
269,788
| – | – | ﹤0.01% | 4024 |
|
|
2021
Q4 | $2.02M | Sell |
269,788
-907
| -0.3% | -$5.84K | ﹤0.01% | 4035 |
|
|
2021
Q3 | $1.9M | Hold |
270,695
| – | – | ﹤0.01% | 4076 |
|
|
2021
Q2 | $2.15M | Hold |
270,695
| – | – | ﹤0.01% | 3951 |
|
|
2021
Q1 | $2.3M | Buy |
270,695
+19,800
| +8% | +$170K | ﹤0.01% | 3831 |
|
|
2020
Q4 | $1.73M | Buy |
250,895
+22,702
| +10% | +$170K | ﹤0.01% | 3703 |
|
|
2020
Q3 | $1.74M | Hold |
228,193
| – | – | ﹤0.01% | 3527 |
|
|
2020
Q2 | $1.58M | Hold |
228,193
| – | – | ﹤0.01% | 3502 |
|
|
2020
Q1 | $1.27M | Buy |
228,193
+182,016
| +394% | +$1.59M | ﹤0.01% | 3433 |
|
|
2019
Q4 | $470K | Hold |
46,177
| – | – | ﹤0.01% | 3810 |
|
|
2019
Q3 | $245K | Hold |
46,177
| – | – | ﹤0.01% | 3929 |
|
|
2019
Q2 | $238K | Hold |
46,177
| – | – | ﹤0.01% | 3949 |
|
|
2019
Q1 | $358K | Buy |
+46,177
| New | +$359K | ﹤0.01% | 3827 |
|
|
2018
Q4 | – | Sell |
-37,903
| Closed | -$280K | – | 4153 |
|
|
2018
Q3 | $280K | Buy |
37,903
+6,522
| +21% | +$56.3K | ﹤0.01% | 3951 |
|
|
2018
Q2 | $348K | Buy |
31,381
+915
| +3% | +$11.1K | ﹤0.01% | 3892 |
|
|
2018
Q1 | $308K | Buy |
30,466
+569
| +2% | +$7.68K | ﹤0.01% | 3886 |
|
|
2017
Q4 | $457K | Buy |
29,897
+9,512
| +47% | +$161K | ﹤0.01% | 3769 |
|
|
2017
Q3 | $358K | Buy |
20,385
+9,719
| +91% | +$171K | ﹤0.01% | 3808 |
|
|
2017
Q2 | $228K | Buy |
10,666
+7,637
| +252% | +$421K | ﹤0.01% | 3878 |
|
|
2017
Q1 | $266K | Buy |
3,029
+1,589
| +110% | +$140K | ﹤0.01% | 3858 |
|
|
2016
Q4 | $132K | Buy |
1,440
+498
| +53% | +$62.9K | ﹤0.01% | 3952 |
|
|
2016
Q3 | $173K | Hold |
942
| – | – | ﹤0.01% | 3923 |
|
|
2016
Q2 | $51K | Sell |
942
-1,049
| -53% | -$303K | ﹤0.01% | 4076 |
|
|
2016
Q1 | $840K | Buy |
1,991
+218
| +12% | +$115K | ﹤0.01% | 3647 |
|
|
2015
Q4 | $1.2M | Buy |
1,773
+64
| +4% | +$47K | ﹤0.01% | 3565 |
|
|
2015
Q3 | $1.16M | Buy |
1,709
+45
| +3% | +$34.2K | ﹤0.01% | 3586 |
|
|
2015
Q2 | $1.46M | Buy |
1,664
+501
| +43% | +$589K | ﹤0.01% | 3545 |
|
|
2015
Q1 | $1.92M | Buy |
1,163
+119
| +11% | +$213K | ﹤0.01% | 3431 |
|
|
2014
Q4 | $1.59M | Buy |
1,044
+89
| +9% | +$162K | ﹤0.01% | 3364 |
|
|
2014
Q3 | $1.95M | Buy |
955
+334
| +54% | +$881K | ﹤0.01% | 3275 |
|
|
2014
Q2 | $2.04M | Buy |
621
+23
| +4% | +$53.1K | ﹤0.01% | 3255 |
|
|
2014
Q1 | $1.3M | Buy |
598
+144
| +32% | +$344K | ﹤0.01% | 3377 |
|
|
2013
Q4 | $905K | Buy |
454
+87
| +24% | +$184K | ﹤0.01% | 3444 |
|
|
2013
Q3 | $999K | Buy |
367
+5
| +1% | +$13.6K | ﹤0.01% | 3365 |
|
|
2013
Q2 | $967K | Buy |
+362
| New | +$1.02M | ﹤0.01% | 3318 |
|
Other funds holding MBOT
6CM
AA
Vanguard Group's MBOT Position: Q4 2025 in Review
Vanguard Group increased its Microbot Medical (MBOT) stake by 42% in Q4 2025, buying an estimated $2.34M and bringing the position to 3,329,721 shares worth $6.66M. The position accounts for ﹤0.01% of the portfolio, ranked #3152.
Vanguard Group first reported a position in MBOT in Q2 2013 and has held it in 50 quarters since. The position peaked at $7.15M in Q3 2025. 70 funds tracked by Wall St. Rank hold MBOT as of Q4 2025.
- Vanguard Group held 3,329,721 shares of Microbot Medical worth $6.66M as of Q4 2025.
- Vanguard Group bought 986,160 Microbot Medical shares in Q4 2025, an estimated $2.34M.
- Microbot Medical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3152 holding.
- Vanguard Group first reported a position in Microbot Medical in Q2 2013 and has held it in 50 quarters since.
- Vanguard Group's Microbot Medical position peaked at $7.15M in Q3 2025.
- 70 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.